NCT01433575View on ClinicalTrials.gov

A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers

PHASE1CompletedINTERVENTIONAL
Enrollment

16

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

November 30, 2011

Study Completion Date

November 30, 2011

Conditions
Healthy Volunteer
Interventions
DRUG

RO4917838

10 mg single oral dose

DRUG

RO4917838

20 mg single oral dose

Trial Locations (1)

100083

Beijing

All Listed Sponsors
lead

Hoffmann-La Roche

INDUSTRY

NCT01433575 - A Pharmacokinetic Study of RO4917838 in Healthy Chinese Volunteers | Biotech Hunter | Biotech Hunter